Live Breaking News & Updates on Alex Stevenson|Page 18
Stay updated with breaking news from Alex stevenson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
4D pharma Announces Positive Interim Results from the Phase I/II Study of the Combination of MRx0518 and KEYTRUDA® for the Treatment of Renal Cell Carcinoma
4D pharma plc (via Public) / 4D pharma Announces Positive Interim Results from the Phase I/II Study of the Combination of MRx0518 and KEYTRUDA® (pembrolizumab) for the Treatment of Renal Cell Carcinoma publicnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicnow.com Daily Mail and Mail on Sunday newspapers.
4D pharma announces positive interim results from the Phase I/II study of the combination of MRx0518 and KEYTRUDA(R) (pembrolizumab) for the treatment of renal cell carcinoma Primary Efficacy Endpoint Met Early in Renal Cell Carcinoma Group in Part B of StudyCompany to Host Conference Call and Webcast Today Mar. ....
4D pharma PLC (AIM:DDDD, NASDAQ:LBPS) jumped 27% in London trading after the company hit its primary efficacy target in a phase I/II trail of one of its. ....